why choose us

First received: August 04, 2023

Clinical Trial: Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Acute Kidney Injury

Study Type: OBSERVATIONAL


Official Title: Combining Biomarkers and Electronic Risk Scores to Predict AKI in Hospitalized Patients

Brief Summary: The study's objective is to evaluate the additive value of renal biomarkers (from blood and urine) for identifying individuals at high risk for severe acute kidney injury (AKI) above that of a novel natural language processing(NLP)-based AKI risk algorithm.The risk algorithm is based on electronic health records (EHR) data (labs, vitals, clinical notes, and test reports).Patients will be enrolled at the University of Chicago Medical Center and the University of Wisconsin Hospital, where the risk score will be…

Read more